🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Vijaya Diagnostic Centre Limited VIJAYA NIFTY_SMALLNSEPHARMA

Healthcare · Diagnostics & Research · India
https://www.vijayadiagnostic.com
Company Profile ↓
₹1,385.90
+37.62% 1Y
Mkt Cap₹14,260.46 Cr
P/E82.54
P/B14.92
Div. Yield0.14%
52W High₹1,397.80
52W Low₹861.40
Book Value₹93.02
EPS (TTM)₹16.79

Company Overview

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 18.1%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 19.2%.

Consistent Profit Growth

Net profit has compounded at 26.9% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 21.1% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 21.2%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹814.20 Cr (+19.5% YoY); net profit ₹172.98 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +19.5%, earnings +20.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR 21.1%, profit CAGR 26.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:21.05%
1 Year:19.49%

Compounded Profit Growth

5 Years:26.91%
1 Year:20.30%

Stock Price Performance

1 Year:+37.62%
6 Months:+39.54%
3 Months:+35.53%
1 Month:+6.72%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 98% of range
₹861.40 ₹1,397.80
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)58.17 · Neutral
Price Performance
1M+6.72%
3M+35.53%
6M+39.54%
1Y+37.62%
Valuation vs Sector

P/E of 82.54 is above the sector median of 39.97 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Excellent profit margin of 21.2%.
  • Compounding revenue at 21.1% over 5 years.
  • Profit CAGR of 26.9% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 82.5.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
82.54
Industry PE
39.97
Forward P/E
52.62
PEG Ratio
-
Book Value
₹93.02
Price to Book
14.92
P/S
17.55
EV/EBITDA
42.81
Dividend Yield
0.14%

Growth (CAGR)

Revenue 5Y
21.05%
Profit 5Y
26.91%
Revenue (YoY)
19.49%
Earnings (YoY)
20.30%

Profitability & Returns

ROCE
19.22%
ROE
18.07%
ROA
11.48%
Profit Margin
21.24%
Op Margin
30.10%
Gross Margin
88.37%
EPS (Latest Qtr)
₹4.65
EPS (TTM)
₹16.79

Balance Sheet & Liquidity

Debt/Equity
0.44
Quick Ratio
2.56
Current Ratio
2.60
Debt
₹422.58 Cr
Total Assets
₹1,507.05 Cr
Current Assets
₹321.90 Cr
Working Capital
₹198.04 Cr

Ownership

Promoter Holding
52.51%
Chg in Prom Hold
0.00%
FII / Inst Holding
36.96%
Chg in FII Hold
0.06%

Financial Snapshot

Enterprise Value
₹14,260.46 Cr
Total Revenue (TTM)
₹814.20 Cr
EBITDA
₹357.73 Cr
Free Cash Flow
₹87.88 Cr
Operating Cash Flow
₹270.59 Cr
Shares Outstanding
₹10.29 Cr
Gross Margin
88.37%
Payout Ratio
11.91%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 VIJAYA Vijaya Diagnostic Centre Limited NIFTY_SMALLNSEPHARMA 1,385.90 82.54 ₹14,260.46 Cr 0.14% 19.22% 18.07% 21.05% 26.91%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 121.00 Cr121.00 Cr139.00 Cr133.00 Cr155.00 Cr156.00 Cr-168.98 Cr173.24 Cr188.05 Cr202.00 Cr205.21 Cr219.38 Cr
Cost of Revenue -------20.85 Cr22.17 Cr21.41 Cr-24.03 Cr24.93 Cr
Gross Profit -------148.13 Cr151.08 Cr166.64 Cr-181.19 Cr194.45 Cr
Operating Expenses 72.00 Cr73.00 Cr82.00 Cr80.00 Cr92.00 Cr95.00 Cr-99.30 Cr101.03 Cr114.00 Cr120.00 Cr119.47 Cr123.26 Cr
Operating Income 38.00 Cr36.00 Cr43.00 Cr37.00 Cr47.00 Cr44.00 Cr-48.83 Cr50.04 Cr52.64 Cr60.00 Cr61.72 Cr71.19 Cr
EBITDA 49.00 Cr48.00 Cr57.00 Cr52.00 Cr63.00 Cr61.00 Cr-71.83 Cr73.38 Cr80.58 Cr82.00 Cr91.16 Cr97.92 Cr
Interest Expense 6.00 Cr6.00 Cr6.00 Cr6.00 Cr6.00 Cr6.00 Cr-6.82 Cr7.19 Cr7.49 Cr8.00 Cr8.59 Cr9.32 Cr
Pretax Income 36.00 Cr35.00 Cr45.00 Cr35.00 Cr44.00 Cr42.00 Cr-46.70 Cr47.37 Cr52.21 Cr58.00 Cr58.22 Cr64.27 Cr
Tax Provision 8.64 Cr9.10 Cr11.25 Cr8.75 Cr10.12 Cr10.50 Cr-11.41 Cr12.51 Cr13.62 Cr14.50 Cr15.05 Cr16.34 Cr
Net Income 28.00 Cr26.00 Cr34.00 Cr26.00 Cr34.00 Cr32.00 Cr-35.30 Cr34.86 Cr38.34 Cr43.00 Cr43.18 Cr47.93 Cr
Diluted EPS 2.692.573.262.533.273.06-3.433.383.754.214.194.65

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 251.00 Cr293.00 Cr339.00 Cr377.00 Cr-459.00 Cr547.58 Cr681.39 Cr814.20 Cr
Cost of Revenue -----58.88 Cr65.44 Cr84.76 Cr94.68 Cr
Gross Profit -----400.12 Cr482.14 Cr596.63 Cr719.52 Cr
Operating Expenses 171.00 Cr184.00 Cr206.00 Cr211.00 Cr-279.68 Cr318.24 Cr394.01 Cr474.41 Cr
Operating Income 54.00 Cr68.00 Cr84.00 Cr116.00 Cr-120.44 Cr163.90 Cr202.62 Cr245.11 Cr
EBITDA 80.00 Cr108.00 Cr133.00 Cr166.00 Cr-194.65 Cr237.64 Cr290.51 Cr357.73 Cr
Interest Expense 5.00 Cr14.00 Cr15.00 Cr15.00 Cr-19.42 Cr21.96 Cr26.74 Cr33.23 Cr
Pretax Income 55.00 Cr65.00 Cr83.00 Cr112.00 Cr-113.51 Cr158.68 Cr193.16 Cr232.68 Cr
Tax Provision 20.35 Cr18.85 Cr20.75 Cr26.88 Cr-28.30 Cr39.04 Cr49.37 Cr59.70 Cr
Net Income 35.00 Cr46.00 Cr63.00 Cr85.00 Cr-84.63 Cr118.83 Cr143.79 Cr172.98 Cr
Diluted EPS 77.44101.29138.0018.64-8.2611.5913.9716.79

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 234.00 Cr406.00 Cr482.00 Cr541.00 Cr-853.41 Cr982.75 Cr1,273.62 Cr1,507.05 Cr
Current Assets -----275.66 Cr211.33 Cr307.21 Cr321.90 Cr
Cash & Equivalents -----24.17 Cr22.24 Cr12.79 Cr39.68 Cr
Inventory -----2.05 Cr5.18 Cr4.93 Cr4.89 Cr
Receivables -----9.49 Cr16.24 Cr14.76 Cr20.86 Cr
Total Liabilities -----306.78 Cr322.84 Cr474.47 Cr549.90 Cr
Current Liabilities -----66.17 Cr72.87 Cr162.61 Cr123.86 Cr
Long Term Debt ----0----
Total Debt 33.00 Cr146.00 Cr161.00 Cr141.00 Cr-247.56 Cr259.18 Cr319.58 Cr422.58 Cr
Total Equity 162.00 Cr208.00 Cr275.00 Cr359.00 Cr-544.73 Cr657.19 Cr795.71 Cr957.15 Cr
Shares Outstanding -----10.21 Cr10.23 Cr10.26 Cr10.29 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 62.00 Cr91.00 Cr106.00 Cr130.00 Cr-164.61 Cr183.30 Cr224.47 Cr270.59 Cr
Investing Cash Flow -98.00 Cr-90.00 Cr-31.00 Cr-130.00 Cr--109.57 Cr-142.31 Cr-181.88 Cr-174.22 Cr
Financing Cash Flow -8.00 Cr-7.00 Cr-30.00 Cr-49.00 Cr--41.91 Cr-44.55 Cr-52.05 Cr-69.49 Cr
Capital Expenditure -30.00 Cr-60.00 Cr-37.00 Cr-32.00 Cr--124.84 Cr-87.96 Cr-95.55 Cr-182.72 Cr
Free Cash Flow 32.00 Cr31.00 Cr69.00 Cr98.00 Cr-39.77 Cr95.34 Cr128.92 Cr87.88 Cr
Net Change in Cash -44.00 Cr-6.00 Cr46.00 Cr-49.00 Cr-13.13 Cr-3.56 Cr-9.45 Cr26.88 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -----87.2%88.0%87.6%88.4%
Operating Margin % 21.5%23.2%24.8%30.8%-26.2%29.9%29.7%30.1%
Net Margin % 13.9%15.7%18.6%22.5%-18.4%21.7%21.1%21.2%
ROE % 21.6%22.1%22.9%23.7%-15.5%18.1%18.1%18.1%
ROCE % -----15.3%18.0%18.2%17.7%

Shareholding Pattern

Insiders
52.51%
Institutions
36.96%
Public Float
77.83%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for VIJAYA

Google News Fri, 10 Jul 2026

Planet Labs (PL) director Vijaya Gadde awarded 6,479 RSUs in new equity grant - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOa2RRdlRJT29vWXNhY0taaklJNUlRa1ZlOHdhTHJyRjVDRXBYSjhIYUdrZmhUWnZ6RTliWV9nd0g2bTd2dkMwLTJtM3FUZWo0RTAzMkpUR2E4SVFVUm9UR0laclpITWtHaVZEWGxweHc2SFRWaUF3U1ExRXdNMmM1Mkp2SEhEV0F2Ym9oNz…

Google News Fri, 03 Jul 2026

ETFs Investing in Vijaya Diagnostic Centre Ltd. Stocks - TradingView

<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE1xdFVjUk1wRzJ5NC1kUlRrQU0wX25mS0dSZTk1bC1EZUdYYkdNcHA5b0JSbUF2cHRjUF9wVnBpQlRtVFpRN2JiUmw0cURsd3prSzdZejBOZE9Wbi1yZ1NzNEt3?oc=5" target="_blank">ETFs Investing in Vijaya Diagnostic…

Google News Mon, 13 Jul 2026

Vijay Kedia portfolio SME stock Exato Technologies zooms 66% in 3 days - Business Standard

<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxPZWR5NE9zZjBSMDYxY2ExNVBRMnZXY25zdTQ3QUQ3b2JaU3lRdDNmRkRQUGp0VnNieGpMbkNDb0dJdkFIQjZ6R2d4MXRmaVBfZHZpNDc5dGQtVDJxZ0w1QTNnV0JmWW53UTZMM0VTMURDaXVfWEppM0d3eU03RS11c3VOYjJnNXBubjdfdV…

Google News ue, 14 Jul 2026

Vijay Kedia’s new smallcap bet revealed; FIIs raise stake, stock up 15% in one month - The Economic Times

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxNaWp0SlNiMWdIYklfOXp0Qm9PNjF0bGhFalRlQ1MxWUR5Q0xxcHJ1eXBCZDhsbnp5NnRvWFR2dXZSYzJBVGx4bkpzRjVRbUpFeGhFamFsMFhQWlc1LWEzSzFCOUxWX2tWclZGYy1SVGJFeEt3MndBZHk5b3RnTEtrZHdrNThwc0JRQ21jRH…

Google News Mon, 29 Jun 2026

Stocks to buy: What's the outlook for Nifty for June 29-July 3 week? Check list of top stock recommendati - The Times of India

<a href="https://news.google.com/rss/articles/CBMiowJBVV95cUxOcGRPdzREQTFvWkd5cnpUMWVyaV9GYm1hNjlUbzVMUlkzX2ZVNlZ2MmhaR19IaUFXaE5RdlhaOU9aNTZ4YmNoZ2MyTnVsT2hETVppQXJOSERFNW1JMXVYaXRlekJnRkIyeGdXTVhsTy1CX2xid284dHVVUHVCZnFDT1ZiSWp3T2FDMllqYn…

Google News hu, 25 Jun 2026

Vijaya Diagnostic gains over 3% as Emkay reiterates buy, sees strong growth across key markets - Moneycontrol.com

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxNZ3hYTFBOZVV2RElXVkJxdjl4T283d28yd3FIbzdGVm5JTENoQlBOdUZXRUlTQ3RBTlozTFBWTmlBM3g3aWZwMEhhYTQzNnJOZmJ6clhzQ29Zd1RpTm5nN1UybG5zYjNBZkhBa1c1VnNTdHM3aE5kcW54aGZ3Rm42U2FHc2VEWXBzeU5IOH…

VIJAYA — Frequently Asked Questions

What is the current share price of Vijaya Diagnostic Centre Limited (VIJAYA)?

As of 2026-07-15 09:52 IST, Vijaya Diagnostic Centre Limited (VIJAYA) trades at ₹1,385.90 on NSE. Its 52-week range is ₹861.40 to ₹1,397.80.

What is the market capitalisation of VIJAYA?

Vijaya Diagnostic Centre Limited (VIJAYA) has a market capitalisation of ₹14,260.46 Cr on NSE.

What is the P/E ratio of VIJAYA?

VIJAYA trades at a trailing price-to-earnings (P/E) ratio of 82.54. The industry average P/E is 39.97. Its price-to-book (P/B) ratio is 14.92.

Does VIJAYA pay a dividend?

Vijaya Diagnostic Centre Limited (VIJAYA) currently offers a dividend yield of 0.14%.

What is the return on equity (ROE) of VIJAYA?

VIJAYA has a return on equity (ROE) of 18.07%. Its return on capital employed (ROCE) is 19.22%.

Is VIJAYA a good stock to buy?

This page provides a data-driven analysis of Vijaya Diagnostic Centre Limited (VIJAYA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space